Original article
Standardization of inhalation provocation tests: Influence of nebulizer output, particle size, and method of inhalation

https://doi.org/10.1016/0091-6749(81)90012-9Get rights and content

Abstract

Standardization of inhalation tests requires a knowledge of factors that will affect the response. We measured the output and particle size of six types of nebulizers used for inhalation tests. Output varied considerably between nebulizers of different types (0.12 to 1.59 ml/min) and to a lesser extent between nebulizers of the same type. Particle size varied between 0.8 and 5.2 μm aerodynamic mass median diameter (AMMD). The influence of these two properties on bronchial response to inhaled methacholine was examined. Nebulizer output but not particle size (between 1.3 and 3.6 μm AMMD) altered the response. We also examined the effect of change in inspiratory time during inhalation from residual volume to total lung capacity on lung deposition of radiolabeled aerosol and on the provocative concentration of histamine required to reduce the 1-sec forced expiratory volume (FEV1) by 20% (PC20). A reduction in inspiratory time from 8 to 2 sec resulted in a lower total lung dose, relatively more aerosol deposited in central airways, and a higher PC20. The results emphasize the importance of keeping nebulizer output and pattern of breathing constant when performing inhalation provocation tests if consistent results are to be obtained.

References (18)

  • MK Benson

    Bronchial hyperreactivity

    Br J Dis Chest

    (1975)
  • TT Mercer et al.

    A multistage low flow rate cascade impactor

    Aerosol Sci

    (1970)
  • MT Newhouse et al.

    Use of scintillation camera and 135Xe for study of topographic pulmonary function

    Respir Physiol

    (1968)
  • RE Ruffin et al.

    The effects of preferential deposition of histamine in the human airway

    Am Rev Respir Dis

    (1978)
  • HA Boushey et al.

    Bronchial hyperreactivity

    Am Rev Respir Dis

    (1980)
  • DW Cockcroft et al.

    Protective effect of drugs on histamine-induced asthma

    Thorax

    (1977)
  • K De Vries et al.

    Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients

    Int Arch Allergy

    (1962)
  • JW Little et al.

    Airways hyperreactivity and peripheral airways dysfunction in influenza A infection

    Am Rev Respir Dis

    (1978)
  • DW Cockcroft et al.

    Allergen-induced increase in non-allergic bronchial reactivity

    Clin Allergy

    (1977)
There are more references available in the full text version of this article.

Cited by (153)

  • A systematic review of methods of citric acid cough reflex testing

    2019, Pulmonary Pharmacology and Therapeutics
  • Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance

    2017, Journal of Allergy and Clinical Immunology: In Practice
  • Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery

    2015, European Journal of Pharmaceutics and Biopharmaceutics
    Citation Excerpt :

    Single bulk material was fed into an air-jet mill (Aljet mill, Fluid Energy, Plumsteadville, PA, USA) with a feed pressure of 80 psi and a grinding pressure of 65 psi. Each bulk material was processed until the 90% particle size was less than 10 μm and 50% reached the respirable range (1–5 μm) [33], and this process was carried out approximately 5–7 times. Samples were collected and analyzed from the collecting chamber.

  • The effects of particle size on measurement of airway hyperresponsiveness to methacholine

    2013, Annals of Allergy, Asthma and Immunology
    Citation Excerpt :

    The difference in particle size resulted in significant difference in the nebulizers' effect despite calibrating and adjusting the nebulizers' output for the inhalation time. This difference contradicts the previous notion, which suggested that a 2.7-fold difference in particle size was not an important determinant of AHR measurement using methacholine PC20 compared with the nebulizer output.8 However, our data are consistent with others that demonstrated that the Wright nebulizer is not the ideal nebulizer for use during methacholine challenge because of underestimation of AHR, which results in a higher PC20, probably due to a very small particle size distribution.16,18

View all citing articles on Scopus

Supported by Medical Research Council of Canada.

Dr. Cockcroft was a Fellow of the Medical Research Council of Canada. Current address: Pulmonary Medicine, University Hospital, Saskatoon, Saskatchewan, Canada.

View full text